Last reviewed · How we verify

intraarticular administration of tranexamic acid

Korea University Guro Hospital · FDA-approved active Small molecule Quality 5/100

intraarticular administration of tranexamic acid is a Small molecule drug developed by Korea University Guro Hospital. It is currently FDA-approved.

At a glance

Generic nameintraarticular administration of tranexamic acid
SponsorKorea University Guro Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about intraarticular administration of tranexamic acid

What is intraarticular administration of tranexamic acid?

intraarticular administration of tranexamic acid is a Small molecule drug developed by Korea University Guro Hospital.

Who makes intraarticular administration of tranexamic acid?

intraarticular administration of tranexamic acid is developed and marketed by Korea University Guro Hospital (see full Korea University Guro Hospital pipeline at /company/korea-university-guro-hospital).

What development phase is intraarticular administration of tranexamic acid in?

intraarticular administration of tranexamic acid is FDA-approved (marketed).

Related